Posts in category New Coverage

Twitter Inc (TWTR) Gains a New Bull Who Advises to “Get in Early” on the Stock

Summit Redstone’s Jonathan Kees thinks the market is underestimating Twitter’s turnaround.

This Analyst Finds It Best to Wait on Buying Square Inc (SQ) Until More Attractive Entry Point Comes Around

Cowen’s Georgios Mihalos makes a neutral case on Square’s opportunity, giving kudos to its “Build with Square” integrated strategy, but seeing growth opportunities priced into the current stock price.

Meet Apple Inc.’s (AAPL) New Skeptic

Wells Fargo’s Aaron Rakers sees 14% upside potential for AAPL stock, but spotlights volatility down the line.

Helios and Matheson Analytics Inc’s (HMNY) Many Monetization Ways Have Attracted a New Bull

Maxim is confident that HMNY’s recent 52% purchase of MoviePass will usher in commercial leverage.

Dynavax Technologies Corporation (DVAX) Gains a Cantor Bull on Back of Compelling HBV Opportunity

Analyst initiates a bullish perspective on Dynavax, ascribing a probability of 95% approval for its lead asset.

Will Pluristem Therapeutics Inc.’s (PSTI) PLX-R18 Help Treat Acute Radiation Syndrome? H.C. Wainwright Weighs in

Analyst Swayampakula Ramakanth of H.C. Wainwright is out with a research note on Pluristem Therapeutics …

Twitter Inc’s (TWTR) Biggest Long-Term Hurdle Is Stubborn MAU Growth; Top Analyst Initiates Hold

Top analyst Youssef Squali of SunTrust sounds off with a cautious report on Twitter Inc (NYSE:TWTR). The …

Show More